Zobrazeno 1 - 10
of 572
pro vyhledávání: '"Peter A. Rasmussen"'
Autor:
Bastijn J. G. van den Boom, Alfredo Elhazaz-Fernandez, Peter A. Rasmussen, Enny H. van Beest, Aishwarya Parthasarathy, Damiaan Denys, Ingo Willuhn
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Deep-brain stimulation (DBS) is an effective treatment for patients suffering from otherwise therapy-resistant psychiatric disorders, including obsessive-compulsive disorder. Modulation of cortico-striatal circuits has been suggested as a me
Externí odkaz:
https://doaj.org/article/29c1b0d582874bfb88142df66736d524
Publikováno v:
Journal of Sport and Health Science, Vol 13, Iss 6, Pp 749-750 (2024)
Externí odkaz:
https://doaj.org/article/55e235d0e36d4d2c8ba0a5f8ae76d169
Autor:
Jacob Tønnesen, Martin H. Ruwald, Jannik Pallisgaard, Peter Vibe Rasmussen, Arne Johannessen, Jim Hansen, Rene H. Worck, Christopher R. Zörner, Lise Riis‐Vestergaard, Charlotte Middelfart, Samuel K. Sørensen, Stefan Sattler, Gunnar Gislason, Morten Lock Hansen
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 7 (2024)
Background Guidelines recommend prioritizing treatment with antiarrhythmic drugs before referral of patients with atrial fibrillation to ablation, delaying a potential subsequent ablation. However, delaying ablation may affect ablation outcomes. We s
Externí odkaz:
https://doaj.org/article/3bc18e8fa6ca459bb81db7229c6477fe
Autor:
Julie Schjødtz Hansen, Fernando Boix, Jørgen Bo Hasselstrøm, Lambert Kristiansen Sørensen, Mads Kjolby, Stefan Gustavsen, Rikke Middelhede Hansen, Thor Petersen, Finn Sellebjerg, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Eva Aggerholm Sædder, Kristina Bacher Svendsen
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Information on the pharmacokinetics (PK) and pharmacodynamics (PD) of orally administered cannabis‐based medicine (CBM) in capsule formulation in patient populations is sparse. In this exploratory study, we aimed to evaluate the PK and PD
Externí odkaz:
https://doaj.org/article/10dc6ec2cd884a1fa87cd0080298e519
Autor:
Tim Spelman, Melinda Magyari, Helmut Butzkueven, Anneke Van Der Walt, Sandra Vukusic, Maria Trojano, Pietro Iaffaldano, Dana Horáková, Jirí Drahota, Fabio Pellegrini, Robert Hyde, Pierre Duquette, Jeannette Lechner-Scott, Seyed Aidin Sajedi, Patrice Lalive, Vahid Shaygannejad, Serkan Ozakbas, Sara Eichau, Raed Alroughani, Murat Terzi, Marc Girard, Tomas Kalincik, Francois Grand'Maison, Olga Skibina, Samia J. Khoury, Bassem Yamout, Maria Jose Sa, Oliver Gerlach, Yolanda Blanco, Rana Karabudak, Celia Oreja-Guevara, Ayse Altintas, Stella Hughes, Pamela McCombe, Radek Ampapa, Koen de Gans, Chris McGuigan, Aysun Soysal, Julie Prevost, Nevin John, Jihad Inshasi, Leszek Stawiarz, Ali Manouchehrinia, Lars Forsberg, Finn Sellebjerg, Anna Glaser, Luigi Pontieri, Hanna Joensen, Peter Vestergaard Rasmussen, Tobias Sejbaek, Mai Bang Poulsen, Jeppe Romme Christensen, Matthias Kant, Morten Stilund, Henrik Mathiesen, Jan Hillert, The Big MS Data Network: a collaboration of the Czech MS Registry, the Danish MS Registry, Italian MS Registry, Swedish MS Registry, MSBase Study Group, and OFSEP
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundTreatment switching is a common challenge and opportunity in real-world clinical practice. Increasing diversity in disease-modifying treatments (DMTs) has generated interest in the identification of reliable and robust predictors of treatme
Externí odkaz:
https://doaj.org/article/3d52ca1fdc794fa48cba7a9cc328885d
Autor:
Stine Dahl Vest, Patrick Rene Gerhard Eriksen, Fleur A. de Groot, Ruben A. L. de Groen, Anne H. R. Kleij, Marina Knudsen Kirkegaard, Peter Kamper, Peter Kristian Rasmussen, Christian von Buchwald, Peter de Nully Brown, Jens Folke Kiilgaard, Joost S. P. Vermaat, Steffen Heegaard
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 6, p 3094 (2024)
To provide insights into targetable oncogenic pathways, this retrospective cohort study investigated the genetic profile of 26 patients with diffuse large B-cell lymphoma, not otherwise specified (DLBCL-NOS), and two patients with high-grade B-cell l
Externí odkaz:
https://doaj.org/article/c45f06d20b494ccab3da7b29c37f8511
Publikováno v:
Forskning og Forandring, Vol 4, Iss 2, Pp 1-22 (2021)
Artiklen argumenterer for, at jo mere praktikere er involveret i at udforske og definere problemstillinger i deres arbejdsliv, des bedre er mulighederne for, at der konstrueres relevante forståelser og handlekompetence. Vi har udviklet metoden den l
Externí odkaz:
https://doaj.org/article/a4d364245bdd450db23122180c3967f2
Autor:
Gunnar Hilmar Gislason, Peter Vibe Rasmussen, Frederik Dalgaard, Jannik Langtved Pallisgaard, Morten Lock Hansen, Tharsika Sakthivel
Publikováno v:
BMJ Open, Vol 12, Iss 9 (2022)
Objectives Atrial fibrillation (AF) is a predominant risk factor of ischaemic stroke and treatment with oral anticoagulants (OACs) is recommended in all patients with risk factors. This study sought to examine treatment patterns of OACs in older pati
Externí odkaz:
https://doaj.org/article/357e2a66e61b4754a6f5342978d107e3
Autor:
Peter Winkel Rasmussen, Henning Osholm Sørensen, Stefan Bruns, Anders Bjorholm Dahl, Anders Nymark Christensen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Dynamic tomography has become an important technique to study fluid flow processes in porous media. The use of laboratory X-ray tomography instruments is, however, limited by their low X-ray brilliance. The prolonged exposure times, in turn,
Externí odkaz:
https://doaj.org/article/96fba20dd6b549f285f7387f8af553a6
Autor:
Viktoria Papp, Mathias Due Buron, Volkert Siersma, Peter Vestergaard Rasmussen, Zsolt Illes, Matthias Kant, Claudia Hilt, Zsolt Mezei, Homayoun Roshanisefat, Tobias Sejbæk, Arkadiusz Weglewski, Janneke van Wingerden, Svend Sparre Geertsen, Stephan Bramow, Finn Sellebjerg, Melinda Magyari
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0250820 (2021)
ObjectiveTeriflunomide is a once-daily, oral disease-modifying therapy (DMT) for relapsing forms of multiple sclerosis (MS). We studied clinical outcomes in a real-world setting involving a population-based large cohort of unselected patients enrolle
Externí odkaz:
https://doaj.org/article/4c38c13ec9ce425b87933408ba9724f9